Description
Jentadueto is a prescription medication containing a combination of Linagliptin (2.5mg) and Metformin hydrochloride (850mg) in film-coated tablet form. Manufactured by Boehringer Ingelheim, this medication is used for the management of type 2 diabetes. Each package contains 60 film-coated tablets designed for oral administration to help control blood glucose levels as part of a comprehensive diabetes treatment plan.
Key features:
• Combination therapy with Linagliptin 2.5mg and Metformin 850mg
• Film-coated tablets for easier swallowing
• Package contains 60 tablets
• Manufactured by Boehringer Ingelheim
• Prescription medication for type 2 diabetes management
• Dual-action formula targeting multiple aspects of blood sugar control
Jentadueto works through a dual mechanism of action: Linagliptin is a DPP-4 inhibitor that increases insulin secretion and decreases glucagon levels, while Metformin reduces glucose production in the liver and improves insulin sensitivity in the body. This combination approach helps address multiple aspects of type 2 diabetes management. The medication is typically taken twice daily with meals to reduce gastrointestinal side effects. As with all prescription medications, it should only be used under the direction and supervision of a healthcare provider.





Reviews
There are no reviews yet.